European generics manufacturers want French government to promote generics more

20 July 2016

by Guillaume Bietry PARIS, July 20 (APM) – European generics […]

Understanding the financial implications of the upcoming falsified medicines regulations

18 July 2016

Commission to Look into ‘Skyrocketing’ EU Drug Prices, Availability, and Patient Access

20 June 2016

Industry Welcomes the European Commission Workshop on the Uptake of Biosimilar Medicines

20 June 2016

The European pharmaceutical industry welcomes the workshop organised today by […]

European Health Ministers Call for More Competition in Pharmaceutical Markets

17 June 2016

Medicines for Europe will engage rapidly with Health Ministers across […]

IGBA Joins ICH and Welcomes the Positive Vote of the General Assembly

15 June 2016

Biosimilar Medicines for Rheumatologists: Bridging the Gap between Regulatory Science and Medical Societies

10 June 2016

Over the past decade, biosimilar medicines have generated more than […]

Generic, Biosimilar and Value Added Medicines Industry Leaders Join Forces to Drive Access to Medicines Agenda

9 June 2016

During the next two days, the key pharmaceutical industry leaders […]

Value Added Medicines: Rethink, Reinvent & Optimise Medicines, Improving Patient Health & Access

31 May 2016

A new study Value Added Medicines: Rethink, Reinvent & Optimise […]

Medicines for Europe Joins Global Campaign to Fight Fake Medicines

27 May 2016

Medicines for Europe, the voice of the generic, biosimilar and […]